Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Pomerantz

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Oncogene|March 2, 1999
Nuclear and nucleolar targeting of human ribosomal protein S25: common features shared with HIV-1 regulatory proteinsS Kubota, T D Copeland, R J Pomerantz
Annals of Internal Medicine|September 23, 2000
Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapyJ A DeSimone, R J Pomerantz, T J Babinchak
Oncogene|April 4, 1996
Cis/trans-activation of the interleukin-9 receptor gene in an HTLV-I-transformed human lymphocytic cellS Kubota, H Siomi, M Hatanaka, et al.
The New England Journal of Medicine|July 30, 1987
Pathogenesis of infection with human immunodeficiency virusD D Ho, R J Pomerantz, J C Kaplan
Virology|March 2, 1999
A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virionsJ Kulkosky, M BouHamdan, A Geist, et al.
Gene Therapy|August 1, 1996
Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapiesM Mukhtar, L Duan, O Bagasra, et al.
Human Gene Therapy|February 19, 2000
Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoirM Mukhtar, H Duke, M BouHamdan, et al.
Antiviral Chemistry & Chemotherapy|August 4, 1999
Role of lentiviral lytic polypeptide I (LLP-I) in the selective cytotoxicity of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1-producing cellsS Kubota, H Zhang, S Kitahara, et al.
Human Gene Therapy|November 24, 1999
A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptideA Jiang, H Fisher, R J Pomerantz, et al.
Virology|January 15, 1999
HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmissionG Dornadula, H Zhang, S Shetty, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Oncogene|March 2, 1999
Nuclear and nucleolar targeting of human ribosomal protein S25: common features shared with HIV-1 regulatory proteinsS Kubota, T D Copeland, R J Pomerantz
Annals of Internal Medicine|September 23, 2000
Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapyJ A DeSimone, R J Pomerantz, T J Babinchak
Oncogene|April 4, 1996
Cis/trans-activation of the interleukin-9 receptor gene in an HTLV-I-transformed human lymphocytic cellS Kubota, H Siomi, M Hatanaka, et al.
The New England Journal of Medicine|July 30, 1987
Pathogenesis of infection with human immunodeficiency virusD D Ho, R J Pomerantz, J C Kaplan
Virology|March 2, 1999
A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virionsJ Kulkosky, M BouHamdan, A Geist, et al.
Gene Therapy|August 1, 1996
Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapiesM Mukhtar, L Duan, O Bagasra, et al.
Human Gene Therapy|February 19, 2000
Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoirM Mukhtar, H Duke, M BouHamdan, et al.
Antiviral Chemistry & Chemotherapy|August 4, 1999
Role of lentiviral lytic polypeptide I (LLP-I) in the selective cytotoxicity of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1-producing cellsS Kubota, H Zhang, S Kitahara, et al.
Human Gene Therapy|November 24, 1999
A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptideA Jiang, H Fisher, R J Pomerantz, et al.
Virology|January 15, 1999
HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmissionG Dornadula, H Zhang, S Shetty, et al.
Pageof 14